Low prevalence of methicillin resistant as determined by an automated identification system in two private hospitals in Nairobi, Kenya: A cross sectional study

BMC Infectious Diseases

Volumn 14, Issue 1, 2015, Pages

  Omuse, Geoffrey ^a   Kabera, Beatrice ^b   Revathi, Gunturu ^a  

^a AGA KHAN UNIVERSITY   (Kenya)

^b Gertrude's Garden Children's Hospital   (Kenya)

Author keywords

Antibiotic susceptibility; MRSA; Staphylococcus aureus

Indexed keywords

CEFOXITIN; CLINDAMYCIN; COTRIFAMOLE; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; MOXIFLOXACIN; OXACILLIN; PENICILLIN DERIVATIVE; PSEUDOMONIC ACID; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT; METICILLIN;

AFRICA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOANALYZER; AUTOMATION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; KENYA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREVALENCE; PRIVATE HOSPITAL; RAPID TEST; SENSITIVITY ANALYSIS; DRUG EFFECTS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PENICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS;

ANTI-BACTERIAL AGENTS; CROSS-SECTIONAL STUDIES; HOSPITALS, PRIVATE; HUMANS; KENYA; METHICILLIN; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; PREVALENCE; STAPHYLOCOCCAL INFECTIONS;

EID: 84923917541     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-014-0669-y     Document Type: Article

References (30)

1. Fluit AC, Wielders CL, Verhoef J, Schmitz FJ: Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study. J Clin Microbiol 2001, 39:3727-3732.
2. Lowy FD: Staphylococcus aureus infections. N Engl J Med 1998, 339:520-532.
3. McDonald LC: Trends in antimicrobial resistance in health care-associated pathogens and effect on treatment. Clin Infect Dis 2006, 42(Suppl 2):S65-S71.
4. Kesah C, Ben Redjeb S, Odugbemi TO, Boye CS, Dosso M, Ndinya Achola JO, Koulla-Shiro S, Benbachir M, Rahal K, Borg M: Prevalence of methicillin-resistant Staphylococcus aureus in eight African hospitals and Malta. Clin Microbiol Infect 2003, 9:153-156.
5. Noskin GA, Rubin RJ, Schentag JJ, Kluytmans J, Hedblom EC, Smulders M, Lapetina E, Gemmen E: The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database. Arch Intern Med 2005, 165:1756-1761.
6. Omari MA, Malonza IM, Bwayo JJ, Mutere AN, Murage EM, Mwatha AK, Ndinya-Achola JO: Pattern of bacterial infections and antimicrobial susceptibility at the Kenyatta National Hospital, Nairobi, Kenya. East Afr Med J 1997, 74:134-137.
7. Tiemersma EW, Bronzwaer SL, Lyytikainen O, Degener JE, Schrijnemakers P, Bruinsma N, Monen J, Witte W, Grundman H: Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 2004, 10:1627-1634.
8. Falagas ME, Karageorgopoulos DE, Leptidis J, Korbila IP: MRSA in Africa: filling the global map of antimicrobial resistance. PLoS One 2013, 8:e68024.
9. Kohli R, Omuse G, Revathi G: Antibacterial susceptibility patterns of blood stream isolates in patients investigated at the Aga Khan University Hospital Nairobi. East Afr Med J 2010, 87:74-80.
10. Maina EK, Kiiyukia C, Wamae CN, Waiyaki PG, Kariuki S: Characterization of methicillin-resistant Staphylococcus aureus from skin and soft tissue infections in patients in Nairobi, Kenya. Int J Infect Dis 2012, 17:e115-e119.
11. Kateete DP, Kimani CN, Katabazi FA, Okeng A, Okee MS, Nanteza A, Joloba ML, Najjuka FC: Identification of Staphylococcus aureus: DNase and Mannitol salt agar improve the efficiency of the tube coagulase test. Ann Clin Microbiol Antimicrob 2010, 9:23.
12. Sperber WH, Tatini SR: Interpretation of the tube coagulase test for identification of Staphylococcus aureus. Appl Microbiol 1975, 29:502-505.
13. Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, Beach M: Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillanc. Clin Infect Dis 2001, 32(Suppl 2):S114-S132.
14. Winstanley T, Courvalin P: Expert systems in clinical microbiology. Clin Microbiol Rev 2011, 24:515-556.
15. Spanu T, Sanguinetti M, Ciccaglione D, D'Inzeo T, Romano L, Leone F, Fadda G: Use of the VITEK 2 system for rapid identification of clinical isolates of Staphylococci from bloodstream infections. J Clin Microbiol 2003, 41:4259-4263.
16. CLSI: Performance standards for antimicrobial susceptibility testing; Twentieth informational supplement. M100-S20, Vol. 29 No 3. Wayne, PA: Clinical Laboratory Standards Institute; 2010.
17. Omuse G, Kariuki S, Revathi G: Unexpected absence of meticillin-resistant Staphylococcus aureus nasal carriage by healthcare workers in a tertiary hospital in Kenya. J Hosp Infect 2012, 80:71-73.
18. Randrianirina F, Soares J-L, Ratsima E, Carod J-F, Combe P, Grosjean P, Richard V, Talarmin A: In vitro activities of 18 antimicrobial agents against Staphylococcus aureus isolates from the Institut Pasteur of Madagascar. Ann Clin Microbiol Antimicrob 2007, 6:5.
19. Naik D, Teclu A: A study on antimicrobial susceptibility pattern in clinical isolates of Staphylococcus aureus in Eritrea. Pan Afr Med J 2009, 3:1.
20. Alabi AS, Frielinghaus L, Kaba H, Kösters K, Huson MA, Kahl BC, Peters G, Grobusch MP, Issifou S, Kremsner PG, Schaumburg F: Retrospective analysis of antimicrobial resistance and bacterial spectrum of infection in Gabon, Central Africa. BMC Infect Dis 2013, 13:455.
21. Chambers HF: Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev 1997, 10:781-791.
22. Skinner S, Murray M, Walus T, Karlowsky JA: Failure of cloxacillin in treatment of a patient with borderline oxacillin-resistant Staphylococcus aureus endocarditis. J Clin Microbiol 2009, 47:859-861.
23. Buchan BW, Ledeboer NA: Identification of two borderline oxacillin-resistant strains of Staphylococcus aureus from routine nares swab specimens by one of three chromogenic agars evaluated for the detection of MRSA. Am J Clin Pathol 2010, 134:921-927.
24. Brink A, Moolman J, da Silva MC, Botha M: Antimicrobial susceptibility profile of selected bacteraemic pathogens from private institutions in South Africa. S Afr Med J 2007, 97:273-279.
25. Egyir B, Guardabassi L, Sørum M, Nielsen SS, Kolekang A, Frimpong E, Addo KK, Newman MJ, Larsen AR: Molecular Epidemiology and Antimicrobial Susceptibility of Clinical Staphylococcus aureus from Healthcare Institutions in Ghana. PLoS One 2014, 9:e89716.
26. Roberts S, Chambers S: Diagnosis and management of Staphylococcus aureus infections of the skin and soft tissue. Intern Med J 2005, 35(Suppl 2):S97-S105.
27. Sabol KE, Echevarria KL, Lewis JS: Community-associated methicillin-resistant Staphylococcus aureus: new bug, old drugs. Ann Pharmacother 2006, 40:1125-1133.
28. Drinkovic D: Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance. J Antimicrob Chemother 2001, 48:315-316.
29. Marais E, Aithma N, Perovic O, Oosthuysen WF, Musenge E, Dusé AG: Antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus isolates from South Africa. S Afr Med J 2009, 99:170-173.
30. Salmenlinna S, Lyytikäinen O, Vuopio-Varkila J: Community-acquired methicillin-resistant Staphylococcus aureus, Finland. Emerg Infect Dis 2002, 8:602-607.